Global Anaesthesia Drugs Market By Anaesthesia Type (General, IV/Monitored Sedation, Regional, Local) By Drug Class (Propofol, Etomidate, Ketamine, Methohexital, Desflurane, Remifentanil, Others) By Route of Administration (Inhalation, Intravenous, Topical) By Surgery Type (Heart Surgery, Brain Surgery, Back Surgeries, Organ Transplants, Knee and Hip Replacements, Others) By end user (Hospitals, Specialty Clinic, Ambulatory Surgical Centres, Others) By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Industry Trends
In order to put patients into a pain-free, sleep-like state prior to surgery or medical procedures, anaesthesia drugs are typically administered as a combination of intravenous (IV) drugs and inhaled gases. Medical procedures that call for anaesthesia drugs include those that take a long time, cause significant blood loss, or take place in a cold environment and affect a patient's breathing. A rising need for critical medical procedures predominantly emergency, orthopedic and cosmetic surgeries will increase demand for anesthesia drugs. Drugs for general anaesthesia are essential in anaesthesiology, and their use in surgery is anticipated to boost anesthesia drugs market growth. The market for anesthesia drugs used during general anaesthesia is anticipated to expand as procedures performed to treat chronic illnesses have become more common. Evolving policies across world regions and inventive technologies for IV drugs may also contribute to growth in the market. Increased rates of chronic illnesses and an ageing population have led to an increase in surgeries. As the older population grows, more procedures are performed, which in turn is raising the demand for anaesthetic medicines.
In terms of revenue, global anesthesia drugs market was valued at US$ 7.03 Bn in 2021 growing at a CAGR of 3.5% over the forecast period (2022 – 2030). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Global Anesthesia Drugs Market Revenue & Forecast, (US$ Million), 2015 – 2030
Type Outlook
General anesthesia drugs had the highest share in the global anesthesia drugs market in 2021. The type of anaesthesia drugs to be administered depends on the severity and duration of the surgery. There are three kinds of anesthesia drugs used during the surgery such as general anesthesia, regional anesthesia, local anesthesia. General anesthesia drugs are given to make patients fall asleep, prevent pain from being felt, and prevent movement during surgery. Whereas on the other hand regional anesthesia numbs a larger area than local anesthesia. It targets specific bundles of nerves. With regional anaesthesia, a patient may get additional anxiety-relieving drugs while they are awake. Although in the last few years, for some surgeries, spinal anesthesia has been increasingly used instead of general anesthesia as a method to provide more comfort to patients and cut down on painkiller use. Additionally, companies are launching combination drugs for effective treatment and surgeries. For instance, in 2021, Heron Therapeutics, Inc. a commercial-stage biotechnology company announced that the U.S. Food and Drug Administration (FDA) has approved ZYNRELEF (bupivacaine and meloxicam) ZYNRELEF, the first and only extended-release dual-acting local anesthetic (DALA). It delivers a fixed-dose combination of the local anesthetic bupivacaine and a low dose of the nonsteroidal anti-inflammatory drug (NSAID) meloxicam. Thus, with such advancements the global anesthesia drugs market is expected to boost during the forecast period.
Route of Administration Outlook
Based on the route of administration, the global anesthesia drugs market is segmented into inhalation, intravenous and topical administrations. Typically, anaesthetics are administered by inhalation or by vein injection. To aid induce sleep before to surgery or other procedures, several anaesthetics may be administered rectally. Drugs that are administered intravenously (IV) swiftly reach significant concentrations in the central nervous system and fast cause anaesthesia. Redistribution to tissues with insufficient blood flow stops their pharmacological effects. The market participants are concentrating on introducing combination and efficient pharmaceuticals to strengthen their market positions and enhance the global anaesthesia drugs market in the next years due to the increase in demand for intravenous anaesthetic drugs.
Region Outlook
Based on the regions, Asia Pacific is anticipated to be the fastest growing region in the anaesthesia drugs market during the forecast period 2022-2030. In the last few years, there has been rise in cosmetics surgeries and procedures which has led to the rise in demand for anaesthesia drugs to reduce pain and inflammation. Moreover the rising geriatric population who are prone to chronic and degenerative diseases have caused an increased verge on surgeries and therapeutics in countries such as India, China and Japan which has led to the rise in demand for anaesthesia drugs and it is thus expected to drive the growth of the anesthesia drugs market. On the other hand, leading market players are looking forward to mergers and acquisitions to expand their product offerings as well as strengthen their presence in the market. Thus with the above factors the anaesthesia drugs market in Asia Pacific region is anticipated to boost during the forecast period 2022-2030.
Competitive Landscape
The report provides both, qualitative and quantitative research of global anesthesia drugs market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the key market participants operating in the global anesthesia drugs market are:
- AbbVie
- Aspen Holdings
- AstraZeneca
- Avet Pharmaceuticals Inc.
- Braun SE
- Baxter
- Fresenius Kabi AG
- GSK plc.
- Hikma Pharmaceuticals PLC
- Par Pharmaceutical.
- Pfizer Inc.
- Piramal Critical Care
- Other Market Participants
Global Anesthesia Drugs Market:
By Anesthesia Type
- General
- IV/Monitored Sedation
- Regional
- Local
By Drug Class
- Propofol
- Etomidate
- Ketamine
- Methohexital
- Desflurane
- Remifentanil
- Others
By Route Of Administration
- Inhalation
- Intravenous
- Topical
By Surgery Type
- Heart Surgery
- Brain Surgery
- Back Surgery
- Organ Transplants
- Knee and Hip Replacements
- Others
By End User
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1.
Market
Scope
1.1. Market Segmentation
1.2. Years Considered
1.2.1. Historic Years: 2015 - 2020
1.2.2. Base Year: 2021
1.2.3. Forecast Years: 2022 – 2030
2.
Key
Target Audiences
3.
Research
Methodology
3.1. Primary Research
3.1.1. Research Questionnaire
3.1.2. Global Percentage Breakdown
3.1.3. Primary Interviews: Key Opinion Leaders
(KOLs)
3.2. Secondary Research
3.2.1. Paid Databases
3.2.2. Secondary Sources
3.3. Market Size Estimates
3.3.1. Top-Down Approach
3.3.2. Bottom-Up Approach
3.4. Data Triangulation Methodology
3.5. Research Assumptions
4.
Recommendations
and Insights from AMI’s Perspective**
5.
Holistic
Overview of Anesthesia Drugs Market
6.
Market
Synopsis: Anesthesia Drugs Market
7.
Anesthesia
Drugs Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product Definition
7.1.2. Industry Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.2.4. Challenges
7.3. Trends in Anesthesia Drugs Market
7.4. Market Determinants Radar Chart
7.5. Macro-Economic and Micro-Economic Indicators:
Anesthesia Drugs Market
7.6. Porter’s Five Force Analysis
7.7. Impact of Covid-19 on Anesthesia Drugs Market
8.
Global
Anesthesia Drugs Market Analysis and Forecasts, 2022 – 2030
8.1. Overview
8.1.1. Global Anesthesia Drugs Market Revenue (US$
Mn)
8.2. Global Anesthesia Drugs Market Revenue (US$
Mn) and Forecasts, By Anesthesia Type
8.2.1. General
8.2.1.1.
Definition
8.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
8.2.1.3.
Market
Forecast, 2022 - 2030
8.2.1.4.
Compound
Annual Growth Rate (CAGR)
8.2.1.5.
Regional
Bifurcation
8.2.1.5.1.
North
America
8.2.1.5.1.1. Market Estimation, 2015 - 2021
8.2.1.5.1.2. Market Forecast, 2022 - 2030
8.2.1.5.2.
Europe
8.2.1.5.2.1. Market Estimation, 2015 - 2021
8.2.1.5.2.2. Market Forecast, 2022 - 2030
8.2.1.5.3.
Asia
Pacific
8.2.1.5.3.1. Market Estimation, 2015 - 2021
8.2.1.5.3.2. Market Forecast, 2022 - 2030
8.2.1.5.4.
Middle
East and Africa
8.2.1.5.4.1. Market Estimation, 2015 - 2021
8.2.1.5.4.2. Market Forecast, 2022 - 2030
8.2.1.5.5.
Latin
America
8.2.1.5.5.1. Market Estimation, 2015 - 2021
8.2.1.5.5.2. Market Forecast, 2022 - 2030
8.2.2. IV/Monitored Sedation
8.2.2.1.
Definition
8.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
8.2.2.3.
Market
Forecast, 2022 - 2030
8.2.2.4.
Compound
Annual Growth Rate (CAGR)
8.2.2.5.
Regional
Bifurcation
8.2.2.5.1.
North
America
8.2.2.5.1.1. Market Estimation, 2015 - 2021
8.2.2.5.1.2. Market Forecast, 2022 - 2030
8.2.2.5.2.
Europe
8.2.2.5.2.1. Market Estimation, 2015 - 2021
8.2.2.5.2.2. Market Forecast, 2022 - 2030
8.2.2.5.3.
Asia
Pacific
8.2.2.5.3.1. Market Estimation, 2015 - 2021
8.2.2.5.3.2. Market Forecast, 2022 - 2030
8.2.2.5.4.
Middle
East and Africa
8.2.2.5.4.1. Market Estimation, 2015 - 2021
8.2.2.5.4.2. Market Forecast, 2022 - 2030
8.2.2.5.5.
Latin
America
8.2.2.5.5.1. Market Estimation, 2015 - 2021
8.2.2.5.5.2. Market Forecast, 2022 - 2030
8.2.3. Regional
8.2.3.1.
Definition
8.2.3.2.
Market
Estimation and Penetration, 2015 - 2021
8.2.3.3.
Market
Forecast, 2022 - 2030
8.2.3.4.
Compound
Annual Growth Rate (CAGR)
8.2.3.5.
Regional
Bifurcation
8.2.3.5.1.
North
America
8.2.3.5.1.1. Market Estimation, 2015 - 2021
8.2.3.5.1.2. Market Forecast, 2022 - 2030
8.2.3.5.2.
Europe
8.2.3.5.2.1. Market Estimation, 2015 - 2021
8.2.3.5.2.2. Market Forecast, 2022 - 2030
8.2.3.5.3.
Asia
Pacific
8.2.3.5.3.1. Market Estimation, 2015 - 2021
8.2.3.5.3.2. Market Forecast, 2022 - 2030
8.2.3.5.4.
Middle
East and Africa
8.2.3.5.4.1. Market Estimation, 2015 - 2021
8.2.3.5.4.2. Market Forecast, 2022 - 2030
8.2.3.5.5.
Latin
America
8.2.3.5.5.1. Market Estimation, 2015 - 2021
8.2.3.5.5.2. Market Forecast, 2022 - 2030
8.2.4. Local
8.2.4.1.
Definition
8.2.4.2.
Market
Estimation and Penetration, 2015 - 2021
8.2.4.3.
Market
Forecast, 2022 - 2030
8.2.4.4.
Compound
Annual Growth Rate (CAGR)
8.2.4.5.
Regional
Bifurcation
8.2.4.5.1.
North
America
8.2.4.5.1.1. Market Estimation, 2015 - 2021
8.2.4.5.1.2. Market Forecast, 2022 - 2030
8.2.4.5.2.
Europe
8.2.4.5.2.1. Market Estimation, 2015 - 2021
8.2.4.5.2.2. Market Forecast, 2022 - 2030
8.2.4.5.3.
Asia
Pacific
8.2.4.5.3.1. Market Estimation, 2015 - 2021
8.2.4.5.3.2. Market Forecast, 2022 - 2030
8.2.4.5.4.
Middle
East and Africa
8.2.4.5.4.1. Market Estimation, 2015 - 2021
8.2.4.5.4.2. Market Forecast, 2022 - 2030
8.2.4.5.5.
Latin
America
8.2.4.5.5.1. Market Estimation, 2015 - 2021
8.2.4.5.5.2. Market Forecast, 2022 - 2030
8.3. Key Segment for Channeling Investments
8.3.1. By Anesthesia Type
9.
Global
Anesthesia Drugs Market Analysis and Forecasts, 2022 – 2030
9.1. Overview
9.2. Global Anesthesia Drugs Market Revenue (US$
Mn) and Forecasts, By Drug Class
9.2.1. Propofol
9.2.1.1.
Definition
9.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.1.3.
Market
Forecast, 2022 - 2030
9.2.1.4.
Compound
Annual Growth Rate (CAGR)
9.2.1.5.
Regional
Bifurcation
9.2.1.5.1.
North
America
9.2.1.5.1.1. Market Estimation, 2015 - 2021
9.2.1.5.1.2. Market Forecast, 2022 - 2030
9.2.1.5.2.
Europe
9.2.1.5.2.1. Market Estimation, 2015 - 2021
9.2.1.5.2.2. Market Forecast, 2022 - 2030
9.2.1.5.3.
Asia
Pacific
9.2.1.5.3.1. Market Estimation, 2015 - 2021
9.2.1.5.3.2. Market Forecast, 2022 - 2030
9.2.1.5.4.
Middle
East and Africa
9.2.1.5.4.1. Market Estimation, 2015 - 2021
9.2.1.5.4.2. Market Forecast, 2022 - 2030
9.2.1.5.5.
Latin
America
9.2.1.5.5.1. Market Estimation, 2015 - 2021
9.2.1.5.5.2. Market Forecast, 2022 - 2030
9.2.2. Etomidate
9.2.2.1.
Definition
9.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.2.3.
Market
Forecast, 2022 - 2030
9.2.2.4.
Compound
Annual Growth Rate (CAGR)
9.2.2.5.
Regional
Bifurcation
9.2.2.5.1.
North
America
9.2.2.5.1.1. Market Estimation, 2015 - 2021
9.2.2.5.1.2. Market Forecast, 2022 - 2030
9.2.2.5.2.
Europe
9.2.2.5.2.1. Market Estimation, 2015 - 2021
9.2.2.5.2.2. Market Forecast, 2022 - 2030
9.2.2.5.3.
Asia
Pacific
9.2.2.5.3.1. Market Estimation, 2015 - 2021
9.2.2.5.3.2. Market Forecast, 2022 - 2030
9.2.2.5.4.
Middle
East and Africa
9.2.2.5.4.1. Market Estimation, 2015 - 2021
9.2.2.5.4.2. Market Forecast, 2022 - 2030
9.2.2.5.5.
Latin
America
9.2.2.5.5.1. Market Estimation, 2015 - 2021
9.2.2.5.5.2. Market Forecast, 2022 - 2030
9.2.3. Ketamine
9.2.3.1.
Definition
9.2.3.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.3.3.
Market
Forecast, 2022 - 2030
9.2.3.4.
Compound
Annual Growth Rate (CAGR)
9.2.3.5.
Regional
Bifurcation
9.2.3.5.1.
North
America
9.2.3.5.1.1. Market Estimation, 2015 - 2021
9.2.3.5.1.2. Market Forecast, 2022 - 2030
9.2.3.5.2.
Europe
9.2.3.5.2.1. Market Estimation, 2015 - 2021
9.2.3.5.2.2. Market Forecast, 2022 - 2030
9.2.3.5.3.
Asia
Pacific
9.2.3.5.3.1. Market Estimation, 2015 - 2021
9.2.3.5.3.2. Market Forecast, 2022 - 2030
9.2.3.5.4.
Middle
East and Africa
9.2.3.5.4.1. Market Estimation, 2015 - 2021
9.2.3.5.4.2. Market Forecast, 2022 - 2030
9.2.3.5.5.
Latin
America
9.2.3.5.5.1. Market Estimation, 2015 - 2021
9.2.3.5.5.2. Market Forecast, 2022 - 2030
9.2.4. Methohexital
9.2.4.1.
Definition
9.2.4.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.4.3.
Market
Forecast, 2022 - 2030
9.2.4.4.
Compound
Annual Growth Rate (CAGR)
9.2.4.5.
Regional
Bifurcation
9.2.4.5.1.
North
America
9.2.4.5.1.1. Market Estimation, 2015 - 2021
9.2.4.5.1.2. Market Forecast, 2022 - 2030
9.2.4.5.2.
Europe
9.2.4.5.2.1. Market Estimation, 2015 - 2021
9.2.4.5.2.2. Market Forecast, 2022 - 2030
9.2.4.5.3.
Asia
Pacific
9.2.4.5.3.1. Market Estimation, 2015 - 2021
9.2.4.5.3.2. Market Forecast, 2022 - 2030
9.2.4.5.4.
Middle
East and Africa
9.2.4.5.4.1. Market Estimation, 2015 - 2021
9.2.4.5.4.2. Market Forecast, 2022 - 2030
9.2.4.5.5.
Latin
America
9.2.4.5.5.1. Market Estimation, 2015 - 2021
9.2.4.5.5.2. Market Forecast, 2022 - 2030
9.2.5. Desflurane
9.2.5.1.
Definition
9.2.5.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.5.3.
Market
Forecast, 2022 - 2030
9.2.5.4.
Compound
Annual Growth Rate (CAGR)
9.2.5.5.
Regional
Bifurcation
9.2.5.5.1.
North
America
9.2.5.5.1.1. Market Estimation, 2015 - 2021
9.2.5.5.1.2. Market Forecast, 2022 - 2030
9.2.5.5.2.
Europe
9.2.5.5.2.1. Market Estimation, 2015 - 2021
9.2.5.5.2.2. Market Forecast, 2022 - 2030
9.2.5.5.3.
Asia
Pacific
9.2.5.5.3.1. Market Estimation, 2015 - 2021
9.2.5.5.3.2. Market Forecast, 2022 - 2030
9.2.5.5.4.
Middle
East and Africa
9.2.5.5.4.1. Market Estimation, 2015 - 2021
9.2.5.5.4.2. Market Forecast, 2022 - 2030
9.2.5.5.5.
Latin
America
9.2.5.5.5.1. Market Estimation, 2015 - 2021
9.2.5.5.5.2. Market Forecast, 2022 - 2030
9.2.6. Remifentanil
9.2.6.1.
Definition
9.2.6.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.6.3.
Market
Forecast, 2022 - 2030
9.2.6.4.
Compound
Annual Growth Rate (CAGR)
9.2.6.5.
Regional
Bifurcation
9.2.6.5.1.
North
America
9.2.6.5.1.1. Market Estimation, 2015 - 2021
9.2.6.5.1.2. Market Forecast, 2022 - 2030
9.2.6.5.2.
Europe
9.2.6.5.2.1. Market Estimation, 2015 - 2021
9.2.6.5.2.2. Market Forecast, 2022 - 2030
9.2.6.5.3.
Asia
Pacific
9.2.6.5.3.1. Market Estimation, 2015 - 2021
9.2.6.5.3.2. Market Forecast, 2022 - 2030
9.2.6.5.4.
Middle
East and Africa
9.2.6.5.4.1. Market Estimation, 2015 - 2021
9.2.6.5.4.2. Market Forecast, 2022 - 2030
9.2.6.5.5.
Latin
America
9.2.6.5.5.1. Market Estimation, 2015 - 2021
9.2.6.5.5.2. Market Forecast, 2022 - 2030
9.2.7. Others
9.2.7.1.
Definition
9.2.7.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.7.3.
Market
Forecast, 2022 - 2030
9.2.7.4.
Compound
Annual Growth Rate (CAGR)
9.2.7.5.
Regional
Bifurcation
9.2.7.5.1.
North
America
9.2.7.5.1.1. Market Estimation, 2015 - 2021
9.2.7.5.1.2. Market Forecast, 2022 - 2030
9.2.7.5.2.
Europe
9.2.7.5.2.1. Market Estimation, 2015 - 2021
9.2.7.5.2.2. Market Forecast, 2022 - 2030
9.2.7.5.3.
Asia
Pacific
9.2.7.5.3.1. Market Estimation, 2015 - 2021
9.2.7.5.3.2. Market Forecast, 2022 - 2030
9.2.7.5.4.
Middle
East and Africa
9.2.7.5.4.1. Market Estimation, 2015 - 2021
9.2.7.5.4.2. Market Forecast, 2022 - 2030
9.2.7.5.5.
Latin
America
9.2.7.5.5.1. Market Estimation, 2015 - 2021
9.2.7.5.5.2. Market Forecast, 2022 - 2030
9.3. Key Segment for Channeling Investments
9.3.1. By Drug Class
10. Global Anesthesia Drugs Market Analysis and
Forecasts, 2022 – 2030
10.1. Overview
10.2. Global Anesthesia Drugs Market Revenue (US$
Mn) and Forecasts, By Route of Administration
10.2.1. Inhalation
10.2.1.1.
Definition
10.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.1.3.
Market
Forecast, 2022 - 2030
10.2.1.4.
Compound
Annual Growth Rate (CAGR)
10.2.1.5.
Regional
Bifurcation
10.2.1.5.1.
North
America
10.2.1.5.1.1. Market Estimation, 2015 - 2021
10.2.1.5.1.2. Market Forecast, 2022 - 2030
10.2.1.5.2.
Europe
10.2.1.5.2.1. Market Estimation, 2015 - 2021
10.2.1.5.2.2. Market Forecast, 2022 - 2030
10.2.1.5.3.
Asia
Pacific
10.2.1.5.3.1. Market Estimation, 2015 - 2021
10.2.1.5.3.2. Market Forecast, 2022 - 2030
10.2.1.5.4.
Middle
East and Africa
10.2.1.5.4.1. Market Estimation, 2015 - 2021
10.2.1.5.4.2. Market Forecast, 2022 - 2030
10.2.1.5.5.
Latin
America
10.2.1.5.5.1. Market Estimation, 2015 - 2021
10.2.1.5.5.2. Market Forecast, 2022 - 2030
10.2.2. Intravenous
10.2.2.1.
Definition
10.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.2.3.
Market
Forecast, 2022 - 2030
10.2.2.4.
Compound
Annual Growth Rate (CAGR)
10.2.2.5.
Regional
Bifurcation
10.2.2.5.1.
North
America
10.2.2.5.1.1. Market Estimation, 2015 - 2021
10.2.2.5.1.2. Market Forecast, 2022 - 2030
10.2.2.5.2.
Europe
10.2.2.5.2.1. Market Estimation, 2015 - 2021
10.2.2.5.2.2. Market Forecast, 2022 - 2030
10.2.2.5.3.
Asia
Pacific
10.2.2.5.3.1. Market Estimation, 2015 - 2021
10.2.2.5.3.2. Market Forecast, 2022 - 2030
10.2.2.5.4.
Middle
East and Africa
10.2.2.5.4.1. Market Estimation, 2015 - 2021
10.2.2.5.4.2. Market Forecast, 2022 - 2030
10.2.2.5.5.
Latin
America
10.2.2.5.5.1. Market Estimation, 2015 - 2021
10.2.2.5.5.2. Market Forecast, 2022 - 2030
10.2.3. Topical
10.2.3.1.
Definition
10.2.3.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.3.3.
Market
Forecast, 2022 - 2030
10.2.3.4.
Compound
Annual Growth Rate (CAGR)
10.2.3.5.
Regional
Bifurcation
10.2.3.5.1.
North
America
10.2.3.5.1.1. Market Estimation, 2015 - 2021
10.2.3.5.1.2. Market Forecast, 2022 - 2030
10.2.3.5.2.
Europe
10.2.3.5.2.1. Market Estimation, 2015 - 2021
10.2.3.5.2.2. Market Forecast, 2022 - 2030
10.2.3.5.3.
Asia
Pacific
10.2.3.5.3.1. Market Estimation, 2015 - 2021
10.2.3.5.3.2. Market Forecast, 2022 - 2030
10.2.3.5.4.
Middle
East and Africa
10.2.3.5.4.1. Market Estimation, 2015 - 2021
10.2.3.5.4.2. Market Forecast, 2022 - 2030
10.2.3.5.5.
Latin
America
10.2.3.5.5.1. Market Estimation, 2015 - 2021
10.2.3.5.5.2. Market Forecast, 2022 - 2030
10.3. Key Segment for Channeling Investments
10.3.1. By Route Of Administration
11. Global Anesthesia Drugs Market Analysis and
Forecasts, 2022 – 2030
11.1. Overview
11.2. Global Anesthesia Drugs Market Revenue (US$
Mn) and Forecasts, By Surgery Type
11.2.1. Heart Surgery
11.2.1.1.
Definition
11.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
11.2.1.3.
Market
Forecast, 2022 - 2030
11.2.1.4.
Compound
Annual Growth Rate (CAGR)
11.2.1.5.
Regional
Bifurcation
11.2.1.5.1.
North
America
11.2.1.5.1.1. Market Estimation, 2015 - 2021
11.2.1.5.1.2. Market Forecast, 2022 - 2030
11.2.1.5.2.
Europe
11.2.1.5.2.1. Market Estimation, 2015 - 2021
11.2.1.5.2.2. Market Forecast, 2022 - 2030
11.2.1.5.3.
Asia
Pacific
11.2.1.5.3.1. Market Estimation, 2015 - 2021
11.2.1.5.3.2. Market Forecast, 2022 - 2030
11.2.1.5.4.
Middle
East and Africa
11.2.1.5.4.1. Market Estimation, 2015 - 2021
11.2.1.5.4.2. Market Forecast, 2022 - 2030
11.2.1.5.5.
Latin
America
11.2.1.5.5.1. Market Estimation, 2015 - 2021
11.2.1.5.5.2. Market Forecast, 2022 - 2030
11.2.2. Brain
Surgery
11.2.2.1.
Definition
11.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
11.2.2.3.
Market
Forecast, 2022 - 2030
11.2.2.4.
Compound
Annual Growth Rate (CAGR)
11.2.2.5.
Regional
Bifurcation
11.2.2.5.1.
North
America
11.2.2.5.1.1. Market Estimation, 2015 - 2021
11.2.2.5.1.2. Market Forecast, 2022 - 2030
11.2.2.5.2.
Europe
11.2.2.5.2.1. Market Estimation, 2015 - 2021
11.2.2.5.2.2. Market Forecast, 2022 - 2030
11.2.2.5.3.
Asia
Pacific
11.2.2.5.3.1. Market Estimation, 2015 - 2021
11.2.2.5.3.2. Market Forecast, 2022 - 2030
11.2.2.5.4.
Middle
East and Africa
11.2.2.5.4.1. Market Estimation, 2015 - 2021
11.2.2.5.4.2. Market Forecast, 2022 - 2030
11.2.2.5.5.
Latin
America
11.2.2.5.5.1. Market Estimation, 2015 - 2021
11.2.2.5.5.2. Market Forecast, 2022 - 2030
11.2.3. Back Surgery
11.2.3.1.
Definition
11.2.3.2.
Market
Estimation and Penetration, 2015 - 2021
11.2.3.3.
Market
Forecast, 2022 - 2030
11.2.3.4.
Compound
Annual Growth Rate (CAGR)
11.2.3.5.
Regional
Bifurcation
11.2.3.5.1.
North America
11.2.3.5.1.1. Market Estimation, 2015 - 2021
11.2.3.5.1.2. Market Forecast, 2022 - 2030
11.2.3.5.2.
Europe
11.2.3.5.2.1. Market Estimation, 2015 - 2021
11.2.3.5.2.2. Market Forecast, 2022 - 2030
11.2.3.5.3.
Asia
Pacific
11.2.3.5.3.1. Market Estimation, 2015 - 2021
11.2.3.5.3.2. Market Forecast, 2022 - 2030
11.2.3.5.4.
Middle
East and Africa
11.2.3.5.4.1. Market Estimation, 2015 - 2021
11.2.3.5.4.2. Market Forecast, 2022 - 2030
11.2.3.5.5.
Latin
America
11.2.3.5.5.1. Market Estimation, 2015 - 2021
11.2.3.5.5.2. Market Forecast, 2022 - 2030
11.2.4. Organ Transplants
11.2.4.1.
Definition
11.2.4.2.
Market
Estimation and Penetration, 2015 - 2021
11.2.4.3.
Market
Forecast, 2022 - 2030
11.2.4.4.
Compound
Annual Growth Rate (CAGR)
11.2.4.5.
Regional
Bifurcation
11.2.4.5.1.
North
America
11.2.4.5.1.1. Market Estimation, 2015 - 2021
11.2.4.5.1.2. Market Forecast, 2022 - 2030
11.2.4.5.2.
Europe
11.2.4.5.2.1. Market Estimation, 2015 - 2021
11.2.4.5.2.2. Market Forecast, 2022 - 2030
11.2.4.5.3.
Asia
Pacific
11.2.4.5.3.1. Market Estimation, 2015 - 2021
11.2.4.5.3.2. Market Forecast, 2022 - 2030
11.2.4.5.4.
Middle
East and Africa
11.2.4.5.4.1. Market Estimation, 2015 - 2021
11.2.4.5.4.2. Market Forecast, 2022 - 2030
11.2.4.5.5.
Latin
America
11.2.4.5.5.1. Market Estimation, 2015 - 2021
11.2.4.5.5.2. Market Forecast, 2022 - 2030
11.2.5. Knee and Hip Replacements
11.2.5.1.
Definition
11.2.5.2.
Market
Estimation and Penetration, 2015 - 2021
11.2.5.3.
Market
Forecast, 2022 - 2030
11.2.5.4.
Compound
Annual Growth Rate (CAGR)
11.2.5.5.
Regional
Bifurcation
11.2.5.5.1.
North
America
11.2.5.5.1.1. Market Estimation, 2015 - 2021
11.2.5.5.1.2. Market Forecast, 2022 - 2030
11.2.5.5.2.
Europe
11.2.5.5.2.1. Market Estimation, 2015 - 2021
11.2.5.5.2.2. Market Forecast, 2022 - 2030
11.2.5.5.3.
Asia
Pacific
11.2.5.5.3.1. Market Estimation, 2015 - 2021
11.2.5.5.3.2. Market Forecast, 2022 - 2030
11.2.5.5.4.
Middle
East and Africa
11.2.5.5.4.1. Market Estimation, 2015 - 2021
11.2.5.5.4.2. Market Forecast, 2022 - 2030
11.2.5.5.5.
Latin
America
11.2.5.5.5.1. Market Estimation, 2015 - 2021
11.2.5.5.5.2. Market Forecast, 2022 - 2030
11.2.6. Others
11.2.6.1.
Definition
11.2.6.2.
Market
Estimation and Penetration, 2015 - 2021
11.2.6.3.
Market
Forecast, 2022 - 2030
11.2.6.4.
Compound
Annual Growth Rate (CAGR)
11.2.6.5.
Regional
Bifurcation
11.2.6.5.1.
North
America
11.2.6.5.1.1. Market Estimation, 2015 - 2021
11.2.6.5.1.2. Market Forecast, 2022 - 2030
11.2.6.5.2.
Europe
11.2.6.5.2.1. Market Estimation, 2015 - 2021
11.2.6.5.2.2. Market Forecast, 2022 - 2030
11.2.6.5.3.
Asia
Pacific
11.2.6.5.3.1. Market Estimation, 2015 - 2021
11.2.6.5.3.2. Market Forecast, 2022 - 2030
11.2.6.5.4.
Middle
East and Africa
11.2.6.5.4.1. Market Estimation, 2015 - 2021
11.2.6.5.4.2. Market Forecast, 2022 - 2030
11.2.6.5.5.
Latin
America
11.2.6.5.5.1. Market Estimation, 2015 - 2021
11.2.6.5.5.2. Market Forecast, 2022 - 2030
11.3. Key Segment for Channeling Investments
11.3.1. By Surgery Type
12. Global Anesthesia Drugs Market Analysis and
Forecasts, 2022 – 2030
12.1. Overview
12.2. Global Anesthesia Drugs Market Revenue (US$
Mn) and Forecasts, By End User
12.2.1. Hospitals
12.2.1.1.
Definition
12.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
12.2.1.3.
Market Forecast,
2022 - 2030
12.2.1.4.
Compound
Annual Growth Rate (CAGR)
12.2.1.5.
Regional
Bifurcation
12.2.1.5.1.
North
America
12.2.1.5.1.1. Market Estimation, 2015 - 2021
12.2.1.5.1.2. Market Forecast, 2022 - 2030
12.2.1.5.2.
Europe
12.2.1.5.2.1. Market Estimation, 2015 - 2021
12.2.1.5.2.2. Market Forecast, 2022 - 2030
12.2.1.5.3.
Asia
Pacific
12.2.1.5.3.1. Market Estimation, 2015 - 2021
12.2.1.5.3.2. Market Forecast, 2022 - 2030
12.2.1.5.4.
Middle
East and Africa
12.2.1.5.4.1. Market Estimation, 2015 - 2021
12.2.1.5.4.2. Market Forecast, 2022 - 2030
12.2.1.5.5.
Latin
America
12.2.1.5.5.1. Market Estimation, 2015 - 2021
12.2.1.5.5.2. Market Forecast, 2022 - 2030
12.2.2. Specialty Clinics
12.2.2.1.
Definition
12.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
12.2.2.3.
Market
Forecast, 2022 - 2030
12.2.2.4.
Compound
Annual Growth Rate (CAGR)
12.2.2.5.
Regional
Bifurcation
12.2.2.5.1.
North
America
12.2.2.5.1.1. Market Estimation, 2015 - 2021
12.2.2.5.1.2. Market Forecast, 2022 - 2030
12.2.2.5.2.
Europe
12.2.2.5.2.1. Market Estimation, 2015 - 2021
12.2.2.5.2.2. Market Forecast, 2022 - 2030
12.2.2.5.3.
Asia
Pacific
12.2.2.5.3.1. Market Estimation, 2015 - 2021
12.2.2.5.3.2. Market Forecast, 2022 - 2030
12.2.2.5.4.
Middle
East and Africa
12.2.2.5.4.1. Market Estimation, 2015 - 2021
12.2.2.5.4.2. Market Forecast, 2022 - 2030
12.2.2.5.5.
Latin
America
12.2.2.5.5.1. Market Estimation, 2015 - 2021
12.2.2.5.5.2. Market Forecast, 2022 - 2030
12.2.3. Ambulatory Surgical Centers
12.2.3.1.
Definition
12.2.3.2.
Market
Estimation and Penetration, 2015 - 2021
12.2.3.3.
Market
Forecast, 2022 - 2030
12.2.3.4.
Compound
Annual Growth Rate (CAGR)
12.2.3.5.
Regional
Bifurcation
12.2.3.5.1.
North
America
12.2.3.5.1.1. Market Estimation, 2015 - 2021
12.2.3.5.1.2. Market Forecast, 2022 - 2030
12.2.3.5.2.
Europe
12.2.3.5.2.1. Market Estimation, 2015 - 2021
12.2.3.5.2.2. Market Forecast, 2022 - 2030
12.2.3.5.3.
Asia
Pacific
12.2.3.5.3.1. Market Estimation, 2015 - 2021
12.2.3.5.3.2. Market Forecast, 2022 - 2030
12.2.3.5.4.
Middle
East and Africa
12.2.3.5.4.1. Market Estimation, 2015 - 2021
12.2.3.5.4.2. Market Forecast, 2022 - 2030
12.2.3.5.5.
Latin
America
12.2.3.5.5.1. Market Estimation, 2015 - 2021
12.2.3.5.5.2. Market Forecast, 2022 - 2030
12.2.4. Others
12.2.4.1.
Definition
12.2.4.2.
Market
Estimation and Penetration, 2015 - 2021
12.2.4.3.
Market
Forecast, 2022 - 2030
12.2.4.4.
Compound
Annual Growth Rate (CAGR)
12.2.4.5.
Regional
Bifurcation
12.2.4.5.1.
North
America
12.2.4.5.1.1. Market Estimation, 2015 - 2021
12.2.4.5.1.2. Market Forecast, 2022 - 2030
12.2.4.5.2.
Europe
12.2.4.5.2.1. Market Estimation, 2015 - 2021
12.2.4.5.2.2. Market Forecast, 2022 - 2030
12.2.4.5.3.
Asia
Pacific
12.2.4.5.3.1. Market Estimation, 2015 - 2021
12.2.4.5.3.2. Market Forecast, 2022 - 2030
12.2.4.5.4.
Middle
East and Africa
12.2.4.5.4.1. Market Estimation, 2015 - 2021
12.2.4.5.4.2. Market Forecast, 2022 - 2030
12.2.4.5.5.
Latin
America
12.2.4.5.5.1. Market Estimation, 2015 - 2021
12.2.4.5.5.2. Market Forecast, 2022 - 2030
12.3. Key Segment for Channeling Investments
12.3.1. By End User
13. North America Anesthesia Drugs Market
Analysis and Forecasts, 2022 - 2030
13.1. Overview
13.1.1. North America Anesthesia Drugs Market Revenue
(US$ Mn)
13.2. North America Anesthesia Drugs Market Revenue
(US$ Mn) and Forecasts, By Anesthesia Type
13.2.1. General
13.2.2. IV/Monitored Sedation
13.2.3. Regional
13.2.4. Local
13.3. North America Anesthesia Drugs Market Revenue
(US$ Mn) and Forecasts, By Drug Class
13.3.1. Propofol
13.3.2. Etomidate
13.3.3. Ketamine
13.3.4. Methohexital
13.3.5. Desflurane
13.3.6. Remifentanil
13.3.7. Others
13.4. North America Anesthesia Drugs Market Revenue
(US$ Mn) and Forecasts, By Route Of Administration
13.4.1. Inhalation
13.4.2. Intravenous
13.4.3. Topical
13.5. North America Anesthesia Drugs Market Revenue
(US$ Mn) and Forecasts, By Surgery Type
13.5.1. Heart Surgery
13.5.2. Brain
Surgery
13.5.3. Back Surgery
13.5.4. Organ Transplants
13.5.5. Knee and Hip Replacements
13.5.6. Others
13.6. North America Anesthesia Drugs Market Revenue
(US$ Mn) and Forecasts, By End User
13.6.1. Hospitals
13.6.2. Specialty Clinics
13.6.3. Ambulatory Surgical Centers
13.6.4. Others
13.7. North America Anesthesia Drugs Market Revenue
(US$ Mn) and Forecasts, By Country
13.7.1. U.S
13.7.1.1.
U.S
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Anesthesia Type
13.7.1.1.1.
General
13.7.1.1.2.
IV/Monitored
Sedation
13.7.1.1.3.
Regional
13.7.1.1.4.
Local
13.7.1.2.
U.S
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Drug Class
13.7.1.2.1.
Propofol
13.7.1.2.2.
Etomidate
13.7.1.2.3.
Ketamine
13.7.1.2.4.
Methohexital
13.7.1.2.5.
Desflurane
13.7.1.2.6.
Remifentanil
13.7.1.2.7.
Others
13.7.1.3.
U.S
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Route Of
Administration
13.7.1.3.1.
Inhalation
13.7.1.3.2.
Intravenous
13.7.1.3.3.
Topical
13.7.1.4.
U.S
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Surgery Type
13.7.1.4.1.
Heart
Surgery
13.7.1.4.2.
Brain Surgery
13.7.1.4.3.
Back
Surgery
13.7.1.4.4.
Organ
Transplants
13.7.1.4.5.
Knee and
Hip Replacements
13.7.1.4.6.
Others
13.7.1.5.
U.S
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By End User
13.7.1.5.1.
Hospitals
13.7.1.5.2.
Specialty
Clinics
13.7.1.5.3.
Ambulatory
Surgical Centers
13.7.1.5.4.
Others
13.7.2. Canada
13.7.2.1.
Canada
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Anesthesia Type
13.7.2.1.1.
General
13.7.2.1.2.
IV/Monitored
Sedation
13.7.2.1.3.
Regional
13.7.2.1.4.
Local
13.7.2.2.
Canada
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Drug Class
13.7.2.2.1.
Propofol
13.7.2.2.2.
Etomidate
13.7.2.2.3.
Ketamine
13.7.2.2.4.
Methohexital
13.7.2.2.5.
Desflurane
13.7.2.2.6.
Remifentanil
13.7.2.2.7.
Others
13.7.2.3.
Canada
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Route Of
Administration
13.7.2.3.1.
Inhalation
13.7.2.3.2.
Intravenous
13.7.2.3.3.
Topical
13.7.2.4.
Canada
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Surgery Type
13.7.2.4.1.
Heart
Surgery
13.7.2.4.2.
Brain Surgery
13.7.2.4.3.
Back
Surgery
13.7.2.4.4.
Organ
Transplants
13.7.2.4.5.
Knee and
Hip Replacements
13.7.2.4.6.
Others
13.7.2.5.
Canada
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By End User
13.7.2.5.1.
Hospitals
13.7.2.5.2.
Specialty
Clinics
13.7.2.5.3.
Ambulatory
Surgical Centers
13.7.2.5.4.
Others
13.7.3. Mexico
13.7.3.1.
Mexico
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Anesthesia Type
13.7.3.1.1.
General
13.7.3.1.2.
IV/Monitored
Sedation
13.7.3.1.3.
Regional
13.7.3.1.4.
Local
13.7.3.2.
Mexico
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Drug Class
13.7.3.2.1.
Propofol
13.7.3.2.2.
Etomidate
13.7.3.2.3.
Ketamine
13.7.3.2.4.
Methohexital
13.7.3.2.5.
Desflurane
13.7.3.2.6.
Remifentanil
13.7.3.2.7.
Others
13.7.3.3.
Mexico
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Route Of
Administration
13.7.3.3.1.
Inhalation
13.7.3.3.2.
Intravenous
13.7.3.3.3.
Topical
13.7.3.4.
Mexico
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Surgery Type
13.7.3.4.1.
Heart
Surgery
13.7.3.4.2.
Brain Surgery
13.7.3.4.3.
Back
Surgery
13.7.3.4.4.
Organ
Transplants
13.7.3.4.5.
Knee and
Hip Replacements
13.7.3.4.6.
Others
13.7.3.5.
Mexico
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By End User
13.7.3.5.1.
Hospitals
13.7.3.5.2.
Specialty
Clinics
13.7.3.5.3.
Ambulatory
Surgical Centers
13.7.3.5.4.
Others
13.7.4. Rest of North America
13.7.4.1.
Rest of
North America Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By
Anesthesia Type
13.7.4.1.1.
General
13.7.4.1.2.
IV/Monitored
Sedation
13.7.4.1.3.
Regional
13.7.4.1.4.
Local
13.7.4.2.
Rest of
North America Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Drug
Class
13.7.4.2.1.
Propofol
13.7.4.2.2.
Etomidate
13.7.4.2.3.
Ketamine
13.7.4.2.4.
Methohexital
13.7.4.2.5.
Desflurane
13.7.4.2.6.
Remifentanil
13.7.4.2.7.
Others
13.7.4.3.
Rest of
North America Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Route
Of Administration
13.7.4.3.1.
Inhalation
13.7.4.3.2.
Intravenous
13.7.4.3.3.
Topical
13.7.4.4.
Rest of
North America Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By
Surgery Type
13.7.4.4.1.
Heart
Surgery
13.7.4.4.2.
Brain Surgery
13.7.4.4.3.
Back
Surgery
13.7.4.4.4.
Organ
Transplants
13.7.4.4.5.
Knee and
Hip Replacements
13.7.4.4.6.
Others
13.7.4.5.
Rest of
North America Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By End
User
13.7.4.5.1.
Hospitals
13.7.4.5.2.
Specialty
Clinics
13.7.4.5.3.
Ambulatory
Surgical Centers
13.7.4.5.4.
Others
13.8. Key Segment for Channeling Investments
13.8.1. By Country
13.8.2. By Anesthesia Type
13.8.3. By Drug Class
13.8.4. By Route Of Administration
13.8.5. By Surgery Type
13.8.6. By End User
14. Europe Anesthesia Drugs Market Analysis and
Forecasts, 2022 - 2030
14.1. Overview
14.1.1. Europe Anesthesia Drugs Market Revenue (US$
Mn)
14.2. Europe Anesthesia Drugs Market Revenue (US$
Mn) and Forecasts, By Anesthesia Type
14.2.1. General
14.2.2. IV/Monitored Sedation
14.2.3. Regional
14.2.4. Local
14.3. Europe Anesthesia Drugs Market Revenue (US$
Mn) and Forecasts, By Drug Class
14.3.1. Propofol
14.3.2. Etomidate
14.3.3. Ketamine
14.3.4. Methohexital
14.3.5. Desflurane
14.3.6. Remifentanil
14.3.7. Others
14.4. Europe Anesthesia Drugs Market Revenue (US$
Mn) and Forecasts, By Route Of Administration
14.4.1. Inhalation
14.4.2. Intravenous
14.4.3. Topical
14.5. Europe Anesthesia Drugs Market Revenue (US$
Mn) and Forecasts, By Surgery Type
14.5.1. Heart Surgery
14.5.2. Brain
Surgery
14.5.3. Back Surgery
14.5.4. Organ Transplants
14.5.5. Knee and Hip Replacements
14.5.6. Others
14.6. Europe Anesthesia Drugs Market Revenue (US$
Mn) and Forecasts, By End User
14.6.1. Hospitals
14.6.2. Specialty Clinics
14.6.3. Ambulatory Surgical Centers
14.6.4. Others
14.7. Europe Anesthesia Drugs Market Revenue (US$
Mn) and Forecasts, By Country
14.7.1. France
14.7.1.1.
France
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Anesthesia Type
14.7.1.1.1.
General
14.7.1.1.2.
IV/Monitored
Sedation
14.7.1.1.3.
Regional
14.7.1.1.4.
Local
14.7.1.2.
France
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Drug Class
14.7.1.2.1.
Propofol
14.7.1.2.2.
Etomidate
14.7.1.2.3.
Ketamine
14.7.1.2.4.
Methohexital
14.7.1.2.5.
Desflurane
14.7.1.2.6.
Remifentanil
14.7.1.2.7.
Others
14.7.1.3.
France
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Route Of
Administration
14.7.1.3.1.
Inhalation
14.7.1.3.2.
Intravenous
14.7.1.3.3.
Topical
14.7.1.4.
France
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Surgery Type
14.7.1.4.1.
Heart
Surgery
14.7.1.4.2.
Brain Surgery
14.7.1.4.3.
Back
Surgery
14.7.1.4.4.
Organ Transplants
14.7.1.4.5.
Knee and
Hip Replacements
14.7.1.4.6.
Others
14.7.1.5.
France
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By End User
14.7.1.5.1.
Hospitals
14.7.1.5.2.
Specialty
Clinics
14.7.1.5.3.
Ambulatory
Surgical Centers
14.7.1.5.4.
Others
14.7.2. The UK
14.7.2.1.
The UK
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Anesthesia Type
14.7.2.1.1.
General
14.7.2.1.2.
IV/Monitored
Sedation
14.7.2.1.3.
Regional
14.7.2.1.4.
Local
14.7.2.2.
The UK
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Drug Class
14.7.2.2.1.
Propofol
14.7.2.2.2.
Etomidate
14.7.2.2.3.
Ketamine
14.7.2.2.4.
Methohexital
14.7.2.2.5.
Desflurane
14.7.2.2.6.
Remifentanil
14.7.2.2.7.
Others
14.7.2.3.
The UK
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Route Of
Administration
14.7.2.3.1.
Inhalation
14.7.2.3.2.
Intravenous
14.7.2.3.3.
Topical
14.7.2.4.
The UK
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Surgery Type
14.7.2.4.1.
Heart
Surgery
14.7.2.4.2.
Brain Surgery
14.7.2.4.3.
Back
Surgery
14.7.2.4.4.
Organ Transplants
14.7.2.4.5.
Knee and
Hip Replacements
14.7.2.4.6.
Others
14.7.2.5.
The UK
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By End User
14.7.2.5.1.
Hospitals
14.7.2.5.2.
Specialty
Clinics
14.7.2.5.3.
Ambulatory
Surgical Centers
14.7.2.5.4.
Others
14.7.3. Spain
14.7.3.1.
Spain
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Anesthesia Type
14.7.3.1.1.
General
14.7.3.1.2.
IV/Monitored
Sedation
14.7.3.1.3.
Regional
14.7.3.1.4.
Local
14.7.3.2.
Spain
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Drug Class
14.7.3.2.1.
Propofol
14.7.3.2.2.
Etomidate
14.7.3.2.3.
Ketamine
14.7.3.2.4.
Methohexital
14.7.3.2.5.
Desflurane
14.7.3.2.6.
Remifentanil
14.7.3.2.7.
Others
14.7.3.3.
Spain
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Route Of
Administration
14.7.3.3.1.
Inhalation
14.7.3.3.2.
Intravenous
14.7.3.3.3.
Topical
14.7.3.4.
Spain
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Surgery Type
14.7.3.4.1.
Heart
Surgery
14.7.3.4.2.
Brain Surgery
14.7.3.4.3.
Back
Surgery
14.7.3.4.4.
Organ Transplants
14.7.3.4.5.
Knee and
Hip Replacements
14.7.3.4.6.
Others
14.7.3.5.
Spain
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By End User
14.7.3.5.1.
Hospitals
14.7.3.5.2.
Specialty
Clinics
14.7.3.5.3.
Ambulatory
Surgical Centers
14.7.3.5.4.
Others
14.7.4. Germany
14.7.4.1.
Germany
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Anesthesia Type
14.7.4.1.1.
General
14.7.4.1.2.
IV/Monitored
Sedation
14.7.4.1.3.
Regional
14.7.4.1.4.
Local
14.7.4.2.
Germany
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Drug Class
14.7.4.2.1.
Propofol
14.7.4.2.2.
Etomidate
14.7.4.2.3.
Ketamine
14.7.4.2.4.
Methohexital
14.7.4.2.5.
Desflurane
14.7.4.2.6.
Remifentanil
14.7.4.2.7.
Others
14.7.4.3.
Germany
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Route Of
Administration
14.7.4.3.1.
Inhalation
14.7.4.3.2.
Intravenous
14.7.4.3.3.
Topical
14.7.4.4.
Germany
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Surgery Type
14.7.4.4.1.
Heart
Surgery
14.7.4.4.2.
Brain Surgery
14.7.4.4.3.
Back
Surgery
14.7.4.4.4.
Organ Transplants
14.7.4.4.5.
Knee and
Hip Replacements
14.7.4.4.6.
Others
14.7.4.5.
Germany
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By End User
14.7.4.5.1.
Hospitals
14.7.4.5.2.
Specialty
Clinics
14.7.4.5.3.
Ambulatory
Surgical Centers
14.7.4.5.4.
Others
14.7.5. Italy
14.7.5.1.
Italy
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Anesthesia Type
14.7.5.1.1.
General
14.7.5.1.2.
IV/Monitored
Sedation
14.7.5.1.3.
Regional
14.7.5.1.4.
Local
14.7.5.2.
Italy
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Drug Class
14.7.5.2.1.
Propofol
14.7.5.2.2.
Etomidate
14.7.5.2.3.
Ketamine
14.7.5.2.4.
Methohexital
14.7.5.2.5.
Desflurane
14.7.5.2.6.
Remifentanil
14.7.5.2.7.
Others
14.7.5.3.
Italy
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Route Of
Administration
14.7.5.3.1.
Inhalation
14.7.5.3.2.
Intravenous
14.7.5.3.3.
Topical
14.7.5.4.
Italy
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Surgery Type
14.7.5.4.1.
Heart
Surgery
14.7.5.4.2.
Brain Surgery
14.7.5.4.3.
Back
Surgery
14.7.5.4.4.
Organ
Transplants
14.7.5.4.5.
Knee and
Hip Replacements
14.7.5.4.6.
Others
14.7.5.5.
Italy
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By End User
14.7.5.5.1.
Hospitals
14.7.5.5.2.
Specialty
Clinics
14.7.5.5.3.
Ambulatory
Surgical Centers
14.7.5.5.4.
Others
14.7.6. Nordic Countries
14.7.6.1.
Nordic
Countries Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Anesthesia
Type
14.7.6.1.1.
General
14.7.6.1.2.
IV/Monitored
Sedation
14.7.6.1.3.
Regional
14.7.6.1.4.
Local
14.7.6.2.
Nordic
Countries Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Drug Class
14.7.6.2.1.
Propofol
14.7.6.2.2.
Etomidate
14.7.6.2.3.
Ketamine
14.7.6.2.4.
Methohexital
14.7.6.2.5.
Desflurane
14.7.6.2.6.
Remifentanil
14.7.6.2.7.
Others
14.7.6.3.
Nordic
Countries Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Route Of
Administration
14.7.6.3.1.
Inhalation
14.7.6.3.2.
Intravenous
14.7.6.3.3.
Topical
14.7.6.4.
Nordic
Countries Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Surgery
Type
14.7.6.4.1.
Heart
Surgery
14.7.6.4.2.
Brain Surgery
14.7.6.4.3.
Back
Surgery
14.7.6.4.4.
Organ
Transplants
14.7.6.4.5.
Knee and
Hip Replacements
14.7.6.4.6.
Others
14.7.6.5.
Nordic
Countries Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By End User
14.7.6.5.1.
Hospitals
14.7.6.5.2.
Specialty
Clinics
14.7.6.5.3.
Ambulatory
Surgical Centers
14.7.6.5.4.
Others
14.7.6.6.
Nordic
Countries Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Country
14.7.6.6.1.
Denmark
14.7.6.6.2.
Finland
14.7.6.6.3.
Iceland
14.7.6.6.4.
Sweden
14.7.6.6.5.
Norway
14.7.7. Benelux Union
14.7.7.1.
Benelux
Union Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Anesthesia
Type
14.7.7.1.1.
General
14.7.7.1.2.
IV/Monitored
Sedation
14.7.7.1.3.
Regional
14.7.7.1.4.
Local
14.7.7.2.
Benelux
Union Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Drug Class
14.7.7.2.1.
Propofol
14.7.7.2.2.
Etomidate
14.7.7.2.3.
Ketamine
14.7.7.2.4.
Methohexital
14.7.7.2.5.
Desflurane
14.7.7.2.6.
Remifentanil
14.7.7.2.7.
Others
14.7.7.3.
Benelux
Union Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Route Of
Administration
14.7.7.3.1.
Inhalation
14.7.7.3.2.
Intravenous
14.7.7.3.3.
Topical
14.7.7.4.
Benelux
Union Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Surgery Type
14.7.7.4.1.
Heart
Surgery
14.7.7.4.2.
Brain Surgery
14.7.7.4.3.
Back
Surgery
14.7.7.4.4.
Organ
Transplants
14.7.7.4.5.
Knee and
Hip Replacements
14.7.7.4.6.
Others
14.7.7.5.
Benelux
Union Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By End User
14.7.7.5.1.
Hospitals
14.7.7.5.2.
Specialty
Clinics
14.7.7.5.3.
Ambulatory
Surgical Centers
14.7.7.5.4.
Others
14.7.7.6.
Benelux
Union Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Country
14.7.7.6.1.
Belgium
14.7.7.6.2.
The
Netherlands
14.7.7.6.3.
Luxembourg
14.7.8. Rest of Europe
14.7.8.1.
Rest of
Europe Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Anesthesia
Type
14.7.8.1.1.
General
14.7.8.1.2.
IV/Monitored
Sedation
14.7.8.1.3.
Regional
14.7.8.1.4.
Local
14.7.8.2.
Rest of
Europe Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Drug Class
14.7.8.2.1.
Propofol
14.7.8.2.2.
Etomidate
14.7.8.2.3.
Ketamine
14.7.8.2.4.
Methohexital
14.7.8.2.5.
Desflurane
14.7.8.2.6.
Remifentanil
14.7.8.2.7.
Others
14.7.8.3.
Rest of
Europe Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Route Of
Administration
14.7.8.3.1.
Inhalation
14.7.8.3.2.
Intravenous
14.7.8.3.3.
Topical
14.7.8.4.
Rest of
Europe Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Surgery Type
14.7.8.4.1.
Heart
Surgery
14.7.8.4.2.
Brain Surgery
14.7.8.4.3.
Back
Surgery
14.7.8.4.4.
Organ
Transplants
14.7.8.4.5.
Knee and
Hip Replacements
14.7.8.4.6.
Others
14.7.8.5.
Rest of
Europe Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By End User
14.7.8.5.1.
Hospitals
14.7.8.5.2.
Specialty
Clinics
14.7.8.5.3.
Ambulatory
Surgical Centers
14.7.8.5.4.
Others
14.8. Key Segment for Channeling Investments
14.8.1. By Country
14.8.2. By Anesthesia Type
14.8.3. By Drug Class
14.8.4. By Route Of Administration
14.8.5. By Surgery Type
14.8.6. By End User
15. Asia Pacific Anesthesia Drugs Market
Analysis and Forecasts, 2022 - 2030
15.1. Overview
15.1.1. Asia Pacific Anesthesia Drugs Market Revenue
(US$ Mn)
15.2. Asia Pacific Anesthesia Drugs Market Revenue
(US$ Mn) and Forecasts, By Anesthesia Type
15.2.1. General
15.2.2. IV/Monitored Sedation
15.2.3. Regional
15.2.4. Local
15.3. Asia Pacific Anesthesia Drugs Market Revenue
(US$ Mn) and Forecasts, By Drug Class
15.3.1. Propofol
15.3.2. Etomidate
15.3.3. Ketamine
15.3.4. Methohexital
15.3.5. Desflurane
15.3.6. Remifentanil
15.3.7. Others
15.4. Asia Pacific Anesthesia Drugs Market Revenue
(US$ Mn) and Forecasts, By Route Of Administration
15.4.1. Inhalation
15.4.2. Intravenous
15.4.3. Topical
15.5. Asia Pacific Anesthesia Drugs Market Revenue
(US$ Mn) and Forecasts, By Surgery Type
15.5.1. Heart Surgery
15.5.2. Brain
Surgery
15.5.3. Back Surgery
15.5.4. Organ Transplants
15.5.5. Knee and Hip Replacements
15.5.6. Others
15.6. Asia Pacific Anesthesia Drugs Market Revenue
(US$ Mn) and Forecasts, By End User
15.6.1. Hospitals
15.6.2. Specialty Clinics
15.6.3. Ambulatory Surgical Centers
15.6.4. Others
15.7. Asia Pacific Anesthesia Drugs Market Revenue
(US$ Mn) and Forecasts, By Country
15.7.1. China
15.7.1.1.
China
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Anesthesia Type
15.7.1.1.1.
General
15.7.1.1.2.
IV/Monitored
Sedation
15.7.1.1.3.
Regional
15.7.1.1.4.
Local
15.7.1.2.
China
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Drug Class
15.7.1.2.1.
Propofol
15.7.1.2.2.
Etomidate
15.7.1.2.3.
Ketamine
15.7.1.2.4.
Methohexital
15.7.1.2.5.
Desflurane
15.7.1.2.6.
Remifentanil
15.7.1.2.7.
Others
15.7.1.3.
China
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Route Of
Administration
15.7.1.3.1.
Inhalation
15.7.1.3.2.
Intravenous
15.7.1.3.3.
Topical
15.7.1.4.
China
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Surgery Type
15.7.1.4.1.
Heart
Surgery
15.7.1.4.2.
Brain Surgery
15.7.1.4.3.
Back
Surgery
15.7.1.4.4.
Organ
Transplants
15.7.1.4.5.
Knee and
Hip Replacements
15.7.1.4.6.
Others
15.7.1.5.
China
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By End User
15.7.1.5.1.
Hospitals
15.7.1.5.2.
Specialty
Clinics
15.7.1.5.3.
Ambulatory
Surgical Centers
15.7.1.5.4.
Others
15.7.2. Japan
15.7.2.1.
Japan
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Anesthesia Type
15.7.2.1.1.
General
15.7.2.1.2.
IV/Monitored
Sedation
15.7.2.1.3.
Regional
15.7.2.1.4.
Local
15.7.2.2.
Japan
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Drug Class
15.7.2.2.1.
Propofol
15.7.2.2.2.
Etomidate
15.7.2.2.3.
Ketamine
15.7.2.2.4.
Methohexital
15.7.2.2.5.
Desflurane
15.7.2.2.6.
Remifentanil
15.7.2.2.7.
Others
15.7.2.3.
Japan
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Route Of
Administration
15.7.2.3.1.
Inhalation
15.7.2.3.2.
Intravenous
15.7.2.3.3.
Topical
15.7.2.4.
Japan
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Surgery Type
15.7.2.4.1.
Heart
Surgery
15.7.2.4.2.
Brain Surgery
15.7.2.4.3.
Back
Surgery
15.7.2.4.4.
Organ
Transplants
15.7.2.4.5.
Knee and
Hip Replacements
15.7.2.4.6.
Others
15.7.2.5.
Japan
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By End User
15.7.2.5.1.
Hospitals
15.7.2.5.2.
Specialty
Clinics
15.7.2.5.3.
Ambulatory
Surgical Centers
15.7.2.5.4.
Others
15.7.3. India
15.7.3.1.
India
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Anesthesia Type
15.7.3.1.1.
General
15.7.3.1.2.
IV/Monitored
Sedation
15.7.3.1.3.
Regional
15.7.3.1.4.
Local
15.7.3.2.
India
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Drug Class
15.7.3.2.1.
Propofol
15.7.3.2.2.
Etomidate
15.7.3.2.3.
Ketamine
15.7.3.2.4.
Methohexital
15.7.3.2.5.
Desflurane
15.7.3.2.6.
Remifentanil
15.7.3.2.7.
Others
15.7.3.3.
India
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Route Of
Administration
15.7.3.3.1.
Inhalation
15.7.3.3.2.
Intravenous
15.7.3.3.3.
Topical
15.7.3.4.
India
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Surgery Type
15.7.3.4.1.
Heart
Surgery
15.7.3.4.2.
Brain Surgery
15.7.3.4.3.
Back
Surgery
15.7.3.4.4.
Organ Transplants
15.7.3.4.5.
Knee and
Hip Replacements
15.7.3.4.6.
Others
15.7.3.5.
India
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By End User
15.7.3.5.1.
Hospitals
15.7.3.5.2.
Specialty
Clinics
15.7.3.5.3.
Ambulatory
Surgical Centers
15.7.3.5.4.
Others
15.7.4. New Zealand
15.7.4.1.
New
Zealand Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Anesthesia
Type
15.7.4.1.1.
General
15.7.4.1.2.
IV/Monitored
Sedation
15.7.4.1.3.
Regional
15.7.4.1.4.
Local
15.7.4.2.
New
Zealand Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Drug Class
15.7.4.2.1.
Propofol
15.7.4.2.2.
Etomidate
15.7.4.2.3.
Ketamine
15.7.4.2.4.
Methohexital
15.7.4.2.5.
Desflurane
15.7.4.2.6.
Remifentanil
15.7.4.2.7.
Others
15.7.4.3.
New
Zealand Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Route Of
Administration
15.7.4.3.1.
Inhalation
15.7.4.3.2.
Intravenous
15.7.4.3.3.
Topical
15.7.4.4.
New
Zealand Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Surgery Type
15.7.4.4.1.
Heart
Surgery
15.7.4.4.2.
Brain Surgery
15.7.4.4.3.
Back
Surgery
15.7.4.4.4.
Organ
Transplants
15.7.4.4.5.
Knee and
Hip Replacements
15.7.4.4.6.
Others
15.7.4.5.
New
Zealand Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By End User
15.7.4.5.1.
Hospitals
15.7.4.5.2.
Specialty
Clinics
15.7.4.5.3.
Ambulatory
Surgical Centers
15.7.4.5.4.
Others
15.7.5. Australia
15.7.5.1.
Australia
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Anesthesia Type
15.7.5.1.1.
General
15.7.5.1.2.
IV/Monitored
Sedation
15.7.5.1.3.
Regional
15.7.5.1.4.
Local
15.7.5.2.
Australia
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Drug Class
15.7.5.2.1.
Propofol
15.7.5.2.2.
Etomidate
15.7.5.2.3.
Ketamine
15.7.5.2.4.
Methohexital
15.7.5.2.5.
Desflurane
15.7.5.2.6.
Remifentanil
15.7.5.2.7.
Others
15.7.5.3.
Australia
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Route Of
Administration
15.7.5.3.1.
Inhalation
15.7.5.3.2.
Intravenous
15.7.5.3.3.
Topical
15.7.5.4.
Australia
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Surgery Type
15.7.5.4.1.
Heart
Surgery
15.7.5.4.2.
Brain Surgery
15.7.5.4.3.
Back
Surgery
15.7.5.4.4.
Organ
Transplants
15.7.5.4.5.
Knee and
Hip Replacements
15.7.5.4.6.
Others
15.7.5.5.
Australia
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By End User
15.7.5.5.1.
Hospitals
15.7.5.5.2.
Specialty
Clinics
15.7.5.5.3.
Ambulatory
Surgical Centers
15.7.5.5.4.
Others
15.7.6. South Korea
15.7.6.1.
South
Korea Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Anesthesia
Type
15.7.6.1.1.
General
15.7.6.1.2.
IV/Monitored
Sedation
15.7.6.1.3.
Regional
15.7.6.1.4.
Local
15.7.6.2.
South
Korea Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Drug Class
15.7.6.2.1.
Propofol
15.7.6.2.2.
Etomidate
15.7.6.2.3.
Ketamine
15.7.6.2.4.
Methohexital
15.7.6.2.5.
Desflurane
15.7.6.2.6.
Remifentanil
15.7.6.2.7.
Others
15.7.6.3.
South
Korea Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Route Of
Administration
15.7.6.3.1.
Inhalation
15.7.6.3.2.
Intravenous
15.7.6.3.3.
Topical
15.7.6.4.
South
Korea Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Surgery Type
15.7.6.4.1.
Heart
Surgery
15.7.6.4.2.
Brain Surgery
15.7.6.4.3.
Back
Surgery
15.7.6.4.4.
Organ Transplants
15.7.6.4.5.
Knee and
Hip Replacements
15.7.6.4.6.
Others
15.7.6.5.
South
Korea Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By End User
15.7.6.5.1.
Hospitals
15.7.6.5.2.
Specialty
Clinics
15.7.6.5.3.
Ambulatory
Surgical Centers
15.7.6.5.4.
Others
15.7.7. Southeast Asia
15.7.7.1.
Southeast
Asia Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Anesthesia Type
15.7.7.1.1.
General
15.7.7.1.2.
IV/Monitored
Sedation
15.7.7.1.3.
Regional
15.7.7.1.4.
Local
15.7.7.2.
Southeast
Asia Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Drug Class
15.7.7.2.1.
Propofol
15.7.7.2.2.
Etomidate
15.7.7.2.3.
Ketamine
15.7.7.2.4.
Methohexital
15.7.7.2.5.
Desflurane
15.7.7.2.6.
Remifentanil
15.7.7.2.7.
Others
15.7.7.3.
Southeast
Asia Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Route Of
Administration
15.7.7.3.1.
Inhalation
15.7.7.3.2.
Intravenous
15.7.7.3.3.
Topical
15.7.7.4.
Southeast
Asia Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Surgery Type
15.7.7.4.1.
Heart
Surgery
15.7.7.4.2.
Brain Surgery
15.7.7.4.3.
Back Surgery
15.7.7.4.4.
Organ
Transplants
15.7.7.4.5.
Knee and
Hip Replacements
15.7.7.4.6.
Others
15.7.7.5.
Southeast
Asia Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By End User
15.7.7.5.1.
Hospitals
15.7.7.5.2.
Specialty
Clinics
15.7.7.5.3.
Ambulatory
Surgical Centers
15.7.7.5.4.
Others
15.7.7.6.
Southeast
Asia Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Country
15.7.7.6.1.
Indonesia
15.7.7.6.2.
Thailand
15.7.7.6.3.
Malaysia
15.7.7.6.4.
Singapore
15.7.7.6.5.
Rest of
Southeast Asia
15.7.8. Rest of Asia Pacific
15.7.8.1.
Rest of
Asia Pacific Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By
Anesthesia Type
15.7.8.1.1.
General
15.7.8.1.2.
IV/Monitored
Sedation
15.7.8.1.3.
Regional
15.7.8.1.4.
Local
15.7.8.2.
Rest of
Asia Pacific Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Drug
Class
15.7.8.2.1.
Propofol
15.7.8.2.2.
Etomidate
15.7.8.2.3.
Ketamine
15.7.8.2.4.
Methohexital
15.7.8.2.5.
Desflurane
15.7.8.2.6.
Remifentanil
15.7.8.2.7.
Others
15.7.8.3.
Rest of
Asia Pacific Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Route
Of Administration
15.7.8.3.1.
Inhalation
15.7.8.3.2.
Intravenous
15.7.8.3.3.
Topical
15.7.8.4.
Rest of
Asia Pacific Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Surgery
Type
15.7.8.4.1.
Heart
Surgery
15.7.8.4.2.
Brain Surgery
15.7.8.4.3.
Back
Surgery
15.7.8.4.4.
Organ
Transplants
15.7.8.4.5.
Knee and
Hip Replacements
15.7.8.4.6.
Others
15.7.8.5.
Rest of
Asia Pacific Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By End
User
15.7.8.5.1.
Hospitals
15.7.8.5.2.
Specialty
Clinics
15.7.8.5.3.
Ambulatory
Surgical Centers
15.7.8.5.4.
Others
15.8. Key Segment for Channeling Investments
15.8.1. By Country
15.8.2. By Anesthesia Type
15.8.3. By Drug Class
15.8.4. By Route Of Administration
15.8.5. By Surgery Type
15.8.6. By End User
16. Middle East and Africa Anesthesia Drugs
Market Analysis and Forecasts, 2022 - 2030
16.1. Overview
16.1.1. Middle East and Africa Anesthesia Drugs
Market Revenue (US$ Mn)
16.2. Middle East and Africa Anesthesia Drugs
Market Revenue (US$ Mn) and Forecasts, By Anesthesia Type
16.2.1. General
16.2.2. IV/Monitored Sedation
16.2.3. Regional
16.2.4. Local
16.3. Middle East and Africa Anesthesia Drugs
Market Revenue (US$ Mn) and Forecasts, By Drug Class
16.3.1. Propofol
16.3.2. Etomidate
16.3.3. Ketamine
16.3.4. Methohexital
16.3.5. Desflurane
16.3.6. Remifentanil
16.3.7. Others
16.4. Middle East and Africa Anesthesia Drugs
Market Revenue (US$ Mn) and Forecasts, By Route Of Administration
16.4.1. Inhalation
16.4.2. Intravenous
16.4.3. Topical
16.5. Middle East and Africa Anesthesia Drugs Market
Revenue (US$ Mn) and Forecasts, By Surgery Type
16.5.1. Heart Surgery
16.5.2. Brain
Surgery
16.5.3. Back Surgery
16.5.4. Organ Transplants
16.5.5. Knee and Hip Replacements
16.5.6. Others
16.6. Middle East and Africa Anesthesia Drugs
Market Revenue (US$ Mn) and Forecasts, By End User
16.6.1. Hospitals
16.6.2. Specialty Clinics
16.6.3. Ambulatory Surgical Centers
16.6.4. Others
16.7. Middle East and Africa Anesthesia Drugs
Market Revenue (US$ Mn) and Forecasts, By Country
16.7.1. Saudi Arabia
16.7.1.1.
Saudi
Arabia Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Anesthesia
Type
16.7.1.1.1.
General
16.7.1.1.2.
IV/Monitored
Sedation
16.7.1.1.3.
Regional
16.7.1.1.4.
Local
16.7.1.2.
Saudi
Arabia Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Drug Class
16.7.1.2.1.
Propofol
16.7.1.2.2.
Etomidate
16.7.1.2.3.
Ketamine
16.7.1.2.4.
Methohexital
16.7.1.2.5.
Desflurane
16.7.1.2.6.
Remifentanil
16.7.1.2.7.
Others
16.7.1.3.
Saudi
Arabia Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Route Of
Administration
16.7.1.3.1.
Inhalation
16.7.1.3.2.
Intravenous
16.7.1.3.3.
Topical
16.7.1.4.
Saudi
Arabia Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Surgery Type
16.7.1.4.1.
Heart
Surgery
16.7.1.4.2.
Brain Surgery
16.7.1.4.3.
Back
Surgery
16.7.1.4.4.
Organ
Transplants
16.7.1.4.5.
Knee and
Hip Replacements
16.7.1.4.6.
Others
16.7.1.5.
Saudi Arabia
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By End User
16.7.1.5.1.
Hospitals
16.7.1.5.2.
Specialty
Clinics
16.7.1.5.3.
Ambulatory
Surgical Centers
16.7.1.5.4.
Others
16.7.2. UAE
16.7.2.1.
UAE
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Anesthesia Type
16.7.2.1.1.
General
16.7.2.1.2.
IV/Monitored
Sedation
16.7.2.1.3.
Regional
16.7.2.1.4.
Local
16.7.2.2.
UAE
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Drug Class
16.7.2.2.1.
Propofol
16.7.2.2.2.
Etomidate
16.7.2.2.3.
Ketamine
16.7.2.2.4.
Methohexital
16.7.2.2.5.
Desflurane
16.7.2.2.6.
Remifentanil
16.7.2.2.7.
Others
16.7.2.3.
UAE
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Route Of
Administration
16.7.2.3.1.
Inhalation
16.7.2.3.2.
Intravenous
16.7.2.3.3.
Topical
16.7.2.4.
UAE
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Surgery Type
16.7.2.4.1.
Heart
Surgery
16.7.2.4.2.
Brain Surgery
16.7.2.4.3.
Back
Surgery
16.7.2.4.4.
Organ
Transplants
16.7.2.4.5.
Knee and
Hip Replacements
16.7.2.4.6.
Others
16.7.2.5.
UAE
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By End User
16.7.2.5.1.
Hospitals
16.7.2.5.2.
Specialty
Clinics
16.7.2.5.3.
Ambulatory
Surgical Centers
16.7.2.5.4.
Others
16.7.3. Egypt
16.7.3.1.
Egypt
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Anesthesia Type
16.7.3.1.1.
General
16.7.3.1.2.
IV/Monitored
Sedation
16.7.3.1.3.
Regional
16.7.3.1.4.
Local
16.7.3.2.
Egypt
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Drug Class
16.7.3.2.1.
Propofol
16.7.3.2.2.
Etomidate
16.7.3.2.3.
Ketamine
16.7.3.2.4.
Methohexital
16.7.3.2.5.
Desflurane
16.7.3.2.6.
Remifentanil
16.7.3.2.7.
Others
16.7.3.3.
Egypt
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Route Of
Administration
16.7.3.3.1.
Inhalation
16.7.3.3.2.
Intravenous
16.7.3.3.3.
Topical
16.7.3.4.
Egypt
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Surgery Type
16.7.3.4.1.
Heart
Surgery
16.7.3.4.2.
Brain Surgery
16.7.3.4.3.
Back
Surgery
16.7.3.4.4.
Organ
Transplants
16.7.3.4.5.
Knee and
Hip Replacements
16.7.3.4.6.
Others
16.7.3.5.
Egypt
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By End User
16.7.3.5.1.
Hospitals
16.7.3.5.2.
Specialty
Clinics
16.7.3.5.3.
Ambulatory
Surgical Centers
16.7.3.5.4.
Others
16.7.4. Kuwait
16.7.4.1.
Kuwait
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Anesthesia Type
16.7.4.1.1.
General
16.7.4.1.2.
IV/Monitored
Sedation
16.7.4.1.3.
Regional
16.7.4.1.4.
Local
16.7.4.2.
Kuwait
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Drug Class
16.7.4.2.1.
Propofol
16.7.4.2.2.
Etomidate
16.7.4.2.3.
Ketamine
16.7.4.2.4.
Methohexital
16.7.4.2.5.
Desflurane
16.7.4.2.6.
Remifentanil
16.7.4.2.7.
Others
16.7.4.3.
Kuwait
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Route Of
Administration
16.7.4.3.1.
Inhalation
16.7.4.3.2.
Intravenous
16.7.4.3.3.
Topical
16.7.4.4.
Kuwait
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Surgery Type
16.7.4.4.1.
Heart
Surgery
16.7.4.4.2.
Brain Surgery
16.7.4.4.3.
Back
Surgery
16.7.4.4.4.
Organ
Transplants
16.7.4.4.5.
Knee and
Hip Replacements
16.7.4.4.6.
Others
16.7.4.5.
Kuwait
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By End User
16.7.4.5.1.
Hospitals
16.7.4.5.2.
Specialty
Clinics
16.7.4.5.3.
Ambulatory
Surgical Centers
16.7.4.5.4.
Others
16.7.5. South Africa
16.7.5.1.
South
Africa Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Anesthesia
Type
16.7.5.1.1.
General
16.7.5.1.2.
IV/Monitored
Sedation
16.7.5.1.3.
Regional
16.7.5.1.4.
Local
16.7.5.2.
South
Africa Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Drug Class
16.7.5.2.1.
Propofol
16.7.5.2.2.
Etomidate
16.7.5.2.3.
Ketamine
16.7.5.2.4.
Methohexital
16.7.5.2.5.
Desflurane
16.7.5.2.6.
Remifentanil
16.7.5.2.7.
Others
16.7.5.3.
South
Africa Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Route Of
Administration
16.7.5.3.1.
Inhalation
16.7.5.3.2.
Intravenous
16.7.5.3.3.
Topical
16.7.5.4.
South
Africa Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Surgery Type
16.7.5.4.1.
Heart
Surgery
16.7.5.4.2.
Brain Surgery
16.7.5.4.3.
Back
Surgery
16.7.5.4.4.
Organ
Transplants
16.7.5.4.5.
Knee and
Hip Replacements
16.7.5.4.6.
Others
16.7.5.5.
South
Africa Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By End User
16.7.5.5.1.
Hospitals
16.7.5.5.2.
Specialty
Clinics
16.7.5.5.3.
Ambulatory
Surgical Centers
16.7.5.5.4.
Others
16.7.6. Rest of Middle East & Africa
16.7.6.1.
Rest of
Middle East & Africa Anesthesia Drugs Market Revenue (US$ Mn) and
Forecasts, By Anesthesia Type
16.7.6.1.1.
General
16.7.6.1.2.
IV/Monitored
Sedation
16.7.6.1.3.
Regional
16.7.6.1.4.
Local
16.7.6.2.
Rest of
Middle East & Africa Anesthesia Drugs Market Revenue (US$ Mn) and
Forecasts, By Drug Class
16.7.6.2.1.
Propofol
16.7.6.2.2.
Etomidate
16.7.6.2.3.
Ketamine
16.7.6.2.4.
Methohexital
16.7.6.2.5.
Desflurane
16.7.6.2.6.
Remifentanil
16.7.6.2.7.
Others
16.7.6.3.
Rest of
Middle East & Africa Anesthesia Drugs Market Revenue (US$ Mn) and
Forecasts, By Route Of Administration
16.7.6.3.1.
Inhalation
16.7.6.3.2.
Intravenous
16.7.6.3.3.
Topical
16.7.6.4.
Rest of
Middle East & Africa Anesthesia Drugs Market Revenue (US$ Mn) and
Forecasts, By Surgery Type
16.7.6.4.1.
Heart
Surgery
16.7.6.4.2.
Brain Surgery
16.7.6.4.3.
Back
Surgery
16.7.6.4.4.
Organ
Transplants
16.7.6.4.5.
Knee and
Hip Replacements
16.7.6.4.6.
Others
16.7.6.5.
Rest of
Middle East & Africa Anesthesia Drugs Market Revenue (US$ Mn) and
Forecasts, By End User
16.7.6.5.1.
Hospitals
16.7.6.5.2.
Specialty
Clinics
16.7.6.5.3.
Ambulatory
Surgical Centers
16.7.6.5.4.
Others
16.8. Key Segment for Channeling Investments
16.8.1. By Country
16.8.2. By Anesthesia Type
16.8.3. By Drug Class
16.8.4. By Route Of Administration
16.8.5. By Surgery Type
16.8.6. By End User
17. Latin America Anesthesia Drugs Market
Analysis and Forecasts, 2022 - 2030
17.1. Overview
17.1.1. Latin America Anesthesia Drugs Market Revenue
(US$ Mn)
17.2. Latin America Anesthesia Drugs Market Revenue
(US$ Mn) and Forecasts, By Anesthesia Type
17.2.1. General
17.2.2. IV/Monitored Sedation
17.2.3. Regional
17.2.4. Local
17.3. Latin America Anesthesia Drugs Market Revenue
(US$ Mn) and Forecasts, By Drug Class
17.3.1. Propofol
17.3.2. Etomidate
17.3.3. Ketamine
17.3.4. Methohexital
17.3.5. Desflurane
17.3.6. Remifentanil
17.3.7. Others
17.4. Latin America Anesthesia Drugs Market Revenue
(US$ Mn) and Forecasts, By Route Of Administration
17.4.1. Inhalation
17.4.2. Intravenous
17.4.3. Topical
17.5. Latin America Anesthesia Drugs Market Revenue
(US$ Mn) and Forecasts, By Surgery Type
17.5.1. Heart Surgery
17.5.2. Brain
Surgery
17.5.3. Back Surgery
17.5.4. Organ Transplants
17.5.5. Knee and Hip Replacements
17.5.6. Others
17.6. Latin America Anesthesia Drugs Market Revenue
(US$ Mn) and Forecasts, By End User
17.6.1. Hospitals
17.6.2. Specialty Clinics
17.6.3. Ambulatory Surgical Centers
17.6.4. Others
17.7. Latin America Anesthesia Drugs Market Revenue
(US$ Mn) and Forecasts, By Country
17.7.1. Brazil
17.7.1.1.
Brazil
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Anesthesia Type
17.7.1.1.1.
General
17.7.1.1.2.
IV/Monitored
Sedation
17.7.1.1.3.
Regional
17.7.1.1.4.
Local
17.7.1.2.
Brazil
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Drug Class
17.7.1.2.1.
Propofol
17.7.1.2.2.
Etomidate
17.7.1.2.3.
Ketamine
17.7.1.2.4.
Methohexital
17.7.1.2.5.
Desflurane
17.7.1.2.6.
Remifentanil
17.7.1.2.7.
Others
17.7.1.3.
Brazil
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Route Of
Administration
17.7.1.3.1.
Inhalation
17.7.1.3.2.
Intravenous
17.7.1.3.3.
Topical
17.7.1.4.
Brazil
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Surgery Type
17.7.1.4.1.
Heart
Surgery
17.7.1.4.2.
Brain Surgery
17.7.1.4.3.
Back
Surgery
17.7.1.4.4.
Organ
Transplants
17.7.1.4.5.
Knee and
Hip Replacements
17.7.1.4.6.
Others
17.7.1.5.
Brazil
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By End User
17.7.1.5.1.
Hospitals
17.7.1.5.2.
Specialty
Clinics
17.7.1.5.3.
Ambulatory
Surgical Centers
17.7.1.5.4.
Others
17.7.2. Argentina
17.7.2.1.
Argentina
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Anesthesia Type
17.7.2.1.1.
General
17.7.2.1.2.
IV/Monitored
Sedation
17.7.2.1.3.
Regional
17.7.2.1.4.
Local
17.7.2.2.
Argentina
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Drug Class
17.7.2.2.1.
Propofol
17.7.2.2.2.
Etomidate
17.7.2.2.3.
Ketamine
17.7.2.2.4.
Methohexital
17.7.2.2.5.
Desflurane
17.7.2.2.6.
Remifentanil
17.7.2.2.7.
Others
17.7.2.3.
Argentina
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Route Of
Administration
17.7.2.3.1.
Inhalation
17.7.2.3.2.
Intravenous
17.7.2.3.3.
Topical
17.7.2.4.
Argentina
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Surgery Type
17.7.2.4.1.
Heart
Surgery
17.7.2.4.2.
Brain Surgery
17.7.2.4.3.
Back
Surgery
17.7.2.4.4.
Organ
Transplants
17.7.2.4.5.
Knee and
Hip Replacements
17.7.2.4.6.
Others
17.7.2.5.
Argentina
Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By End User
17.7.2.5.1.
Hospitals
17.7.2.5.2.
Specialty
Clinics
17.7.2.5.3.
Ambulatory
Surgical Centers
17.7.2.5.4.
Others
17.7.3. Rest of Latin America
17.7.3.1.
Rest of
Latin America Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By
Anesthesia Type
17.7.3.1.1.
General
17.7.3.1.2.
IV/Monitored
Sedation
17.7.3.1.3.
Regional
17.7.3.1.4.
Local
17.7.3.2.
Rest of
Latin America Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Drug
Class
17.7.3.2.1.
Propofol
17.7.3.2.2.
Etomidate
17.7.3.2.3.
Ketamine
17.7.3.2.4.
Methohexital
17.7.3.2.5.
Desflurane
17.7.3.2.6.
Remifentanil
17.7.3.2.7.
Others
17.7.3.3.
Rest of
Latin America Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By Route
Of Administration
17.7.3.3.1.
Inhalation
17.7.3.3.2.
Intravenous
17.7.3.3.3.
Topical
17.7.3.4.
Rest of
Latin America Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By
Surgery Type
17.7.3.4.1.
Heart
Surgery
17.7.3.4.2.
Brain Surgery
17.7.3.4.3.
Back
Surgery
17.7.3.4.4.
Organ
Transplants
17.7.3.4.5.
Knee and
Hip Replacements
17.7.3.4.6.
Others
17.7.3.5.
Rest of
Latin America Anesthesia Drugs Market Revenue (US$ Mn) and Forecasts, By End
User
17.7.3.5.1.
Hospitals
17.7.3.5.2.
Specialty
Clinics
17.7.3.5.3.
Ambulatory
Surgical Centers
17.7.3.5.4.
Others
17.8. Key Segment for Channeling Investments
17.8.1. By Country
17.8.2. By Anesthesia Type
17.8.3. By Drug Class
17.8.4. By Route Of Administration
17.8.5. By Surgery Type
17.8.6. By End User
18. Competitive Benchmarking
18.1. Brand Benchmarking
18.2. Market Share Analysis, 2021
18.3. Global Presence and Growth Strategies
18.3.1. Mergers and Acquisitions
18.3.2. Product Launches
18.3.3. Investments Trends
18.3.4. R&D Initiatives
19. Player Profiles
19.1. AbbVie
19.1.1. Company Details
19.1.2. Company Overview
19.1.3. Product Offerings
19.1.4. Key Developments
19.1.5. Financial Analysis
19.1.6. SWOT Analysis
19.1.7. Business Strategies
19.2. Aspen Holdings
19.2.1. Company Details
19.2.2. Company Overview
19.2.3. Product Offerings
19.2.4. Key Developments
19.2.5. Financial Analysis
19.2.6. SWOT Analysis
19.2.7. Business Strategies
19.3. AstraZeneca
19.3.1. Company Details
19.3.2. Company Overview
19.3.3. Product Offerings
19.3.4. Key Developments
19.3.5. Financial Analysis
19.3.6. SWOT Analysis
19.3.7. Business Strategies
19.4. Avet Pharmaceuticals Inc.
19.4.1. Company Details
19.4.2. Company Overview
19.4.3. Product Offerings
19.4.4. Key Developments
19.4.5. Financial Analysis
19.4.6. SWOT Analysis
19.4.7. Business Strategies
19.5. B. Braun SE
19.5.1. Company Details
19.5.2. Company Overview
19.5.3. Product Offerings
19.5.4. Key Developments
19.5.5. Financial Analysis
19.5.6. SWOT Analysis
19.5.7. Business Strategies
19.6. Baxter
19.6.1. Company Details
19.6.2. Company Overview
19.6.3. Product Offerings
19.6.4. Key Developments
19.6.5. Financial Analysis
19.6.6. SWOT Analysis
19.6.7. Business Strategies
19.7. Fresenius Kabi AG
19.7.1. Company Details
19.7.2. Company Overview
19.7.3. Product Offerings
19.7.4. Key Developments
19.7.5. Financial Analysis
19.7.6. SWOT Analysis
19.7.7. Business Strategies
19.8. GSK plc.
19.8.1. Company Details
19.8.2. Company Overview
19.8.3. Product Offerings
19.8.4. Key Developments
19.8.5. Financial Analysis
19.8.6. SWOT Analysis
19.8.7. Business Strategies
19.9. Hikma Pharmaceuticals PLC
19.9.1. Company Details
19.9.2. Company Overview
19.9.3. Product Offerings
19.9.4. Key Developments
19.9.5. Financial Analysis
19.9.6. SWOT Analysis
19.9.7. Business Strategies
19.10. Par Pharmaceutical.
19.10.1. Company Details
19.10.2. Company Overview
19.10.3. Product Offerings
19.10.4. Key Developments
19.10.5. Financial Analysis
19.10.6. SWOT Analysis
19.10.7. Business Strategies
19.11. Pfizer Inc.
19.11.1. Company Details
19.11.2. Company Overview
19.11.3. Product Offerings
19.11.4. Key Developments
19.11.5. Financial Analysis
19.11.6. SWOT Analysis
19.11.7. Business Strategies
19.12. Piramal Critical Care
19.12.1. Company Details
19.12.2. Company Overview
19.12.3. Product Offerings
19.12.4. Key Developments
19.12.5. Financial Analysis
19.12.6. SWOT Analysis
19.12.7. Business Strategies
19.13. Other Market Participants
20. Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User and
Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
